Xponance Inc. Increases Stock Holdings in McKesson Co. (NYSE:MCK)

Xponance Inc. boosted its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 1.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,592 shares of the company's stock after acquiring an additional 534 shares during the quarter. Xponance Inc.'s holdings in McKesson were worth $16,865,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the stock. Frank Rimerman Advisors LLC boosted its position in McKesson by 2.2% during the 4th quarter. Frank Rimerman Advisors LLC now owns 807 shares of the company's stock worth $460,000 after buying an additional 17 shares during the period. Old North State Trust LLC boosted its position in McKesson by 1.6% during the 3rd quarter. Old North State Trust LLC now owns 1,138 shares of the company's stock worth $563,000 after buying an additional 18 shares during the period. Trust Co. of Vermont boosted its position in McKesson by 4.8% during the 4th quarter. Trust Co. of Vermont now owns 393 shares of the company's stock worth $224,000 after buying an additional 18 shares during the period. Hemington Wealth Management boosted its position in McKesson by 18.6% during the 4th quarter. Hemington Wealth Management now owns 115 shares of the company's stock worth $65,000 after buying an additional 18 shares during the period. Finally, Calamos Wealth Management LLC lifted its position in shares of McKesson by 0.4% in the 4th quarter. Calamos Wealth Management LLC now owns 4,677 shares of the company's stock worth $2,665,000 after purchasing an additional 20 shares during the period. 85.07% of the stock is owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

MCK has been the topic of a number of recent analyst reports. Bank of America dropped their price target on shares of McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Evercore ISI boosted their target price on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research report on Thursday, February 6th. Morgan Stanley boosted their target price on shares of McKesson from $612.00 to $642.00 and gave the company an "overweight" rating in a research report on Tuesday, December 17th. StockNews.com downgraded shares of McKesson from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Finally, Mizuho started coverage on shares of McKesson in a research report on Wednesday, December 4th. They set a "neutral" rating and a $630.00 target price on the stock. Two research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $649.36.

Insider Transactions at McKesson

In related news, EVP Leann B. Smith sold 188 shares of the business's stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total value of $114,602.92. Following the transaction, the executive vice president now directly owns 1,051 shares of the company's stock, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the completion of the transaction, the chief executive officer now directly owns 60,664 shares in the company, valued at $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 18,689 shares of company stock worth $11,187,351 in the last quarter. 0.11% of the stock is currently owned by corporate insiders.

McKesson Stock Down 1.0 %

MCK stock traded down $6.91 during midday trading on Friday, reaching $659.45. 1,969,537 shares of the company's stock traded hands, compared to its average volume of 799,367. The company has a market cap of $82.65 billion, a price-to-earnings ratio of 30.19, a P/E/G ratio of 1.29 and a beta of 0.52. The firm's fifty day moving average price is $616.14 and its 200-day moving average price is $574.33. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $670.79.

McKesson (NYSE:MCK - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Analysts forecast that McKesson Co. will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be paid a $0.71 dividend. The ex-dividend date is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.43%. McKesson's payout ratio is 13.00%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.